Major Expansion in Capacity for Brecon Pharmaceuticals

Commercial packaging and clinical trials services specialist Brecon Pharmaceuticals announced the expansion of its storage and distribution capacity, with investment in a purpose-built facility in South Wales. Responding to customer demand the new site will provide a further 23,000 ft2 of temperature-controlled storage facilities and eight dispatch lanes.

The investment in the new site is part of the company’s ambitious growth strategy and demonstrates its commitment to growing and innovating to meet the changing needs of the pharmaceutical and biotechnology sectors. Enabling even faster turnaround times and access to a broader range of services, the facility at Treforest is strategically
located to facilitate access to all major UK airports and road networks - guaranteeing 24-hour national and efficient worldwide distribution.

“Brecon is focused on the rapidly-changing needs of the industries in which we operate and is expanding capacity and innovating services to meet our clients’ needs,” said Peter Belden, Managing Director. “This latest temperature-controlled addition has been designed to meet the highest standards in clinical trial and commercial product handling
including the ability to manage ambient, cold and frozen conditions.”

Brecon Pharmaceuticals and its sister company in the United States, Anderson Packaging, support clients from the earliest stage of R&D through clinical trial and filing and on to commercialisation, packaging and supply. It works with a wide range of clients from small, ‘virtual’ companies through to the biggest global pharmaceutical organisations.
“This latest investment demonstrates our commitment to providing our customers with a seamless global offering,” added Belden.